Facilities
Panacea Biotec has established and is operating high standard cGMP manufacturing facilities for pharmaceutical formulation & vaccines with accreditation from various international organizations and regulatory bodies.
Pharmaceutical Formulation Plant
Baddi, Himachal Pradesh, India
Situated amidst picturesque surroundings in the state of Himachal Pradesh, Panacea Biotec’s facility in Baddi is currently catering to manufacturing of oral pharmaceutical finished dosage forms. The facility is equipped with modern equipment and machinery to met the regulatory standards of the US, European & South African markets.
The facility is spread over 70,000 sqm with dedicated blocks for
Tablets, Hard Gelatin Capsules, Liquid Orals & Ointments
Soft Gelatin formulation with a dedicated line for immunosuppressants
Dietary Supplements / Herbal Formulations : Tablets / Capsules/ Ointments
Rifampicin based oral finished dosage forms
Vaccine Formulation Plant
New Delhi, India
This is a state of the art manufacturing facility located in the capital of India, New Delhi. With a built up area of more than more than 50,000 sq ft. it has three vial filling lines
Two lines are dedicated to production of Oral Polio Vaccines both Trivalent & Monovalent
One line is dedicated to the manufacturing of Hepatitis B & Combination Vaccines
This is a WHO cGMP approved facility with WHO Pre-qualification for Oral Polio Vaccines. The facility has been designed, constructed and maintained to suit production of vaccines following Good Manufacturing Practices. Provision has also been made for a separate filling line for prefilled injection devices.
Vaccine Formulation Plant
Lalru, Punjab, India
This facility has been set up to manufacture recombinant Hepatitis B Vaccine along with other products using recombinant DNA technology for filling, packing and final processing. This facility is spread over 50 acres and the complex also houses facilities for Research and Development Laboratories, Animal House and Effluent Treatment Plant.
The manufacturing facility includes physically segregated Upstream processing area, Down stream processing area, Formulation area, Cold rooms and Critical systems & utility area. The premises is designed, constructed, adapted and maintained to suit the production of recombinant vaccines following current Good Manufacturing Practices (cGMPs). The layout and design aims to minimize the risk of errors and permit effective cleaning and maintenance in order to avoid contamination, mix-up, and unidirectional personnel and material flow. Separate cold rooms are provided for the storage of in process and the finished products under quarantine and release.
Upcoming Facilities
State-of-the-art manufacturing facilities for Bacterial Product vaccines.
Facility for Cell Culture based vaccines.
Upcoming Fermentation based Pilot Plant for scale-up studies of new vaccines and biopharmaceutical
A new Vaccine Formulation and Filling Unit under construction to meet requirement of final product filling and packaging.
|
|
|
|
Manufacturing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
